GlassScriptPhysician profile
Anjali Patel
NPI 1801329404
$864.75
in general payments reported to CMS, 2019-2025
18 companies · $447 in 2025
The $447 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.36 · 2023: $62.88 · 2024: $300 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $171.47 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $91.55 | 2023-2025 | Airsupra, Tezspire, Breztri |
| Insmed, INC. | $80.64 | 2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $75.42 | 2024-2025 | Dupixent |
| Baxter Healthcare | $49.48 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Vifor Pharma, INC. | $44.31 | 2024 | Zemaira |
| Inspire Medical Systems, INC. | $43.55 | 2024 | Inspire |
| Biocodex, INC. | $32.78 | 2025 | |
| Abbvie INC. | $30.53 | 2024 | |
| Jazz Pharmaceuticals INC. | $28.80 | 2025 | |
| United Therapeutics Corporation | $24.77 | 2023 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $24.77 | 2025 | Opsumit, Uptravi |
| Pfizer INC. | $23.65 | 2025 | |
| Genzyme Corporation | $20.42 | 2025 | |
| Verona Pharma, INC. | $18.49 | 2025 | Ohtuvayre |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $17.57 | 2024 | |
| Philips North America LLC | $17.20 | 2024 | (Ak6) Vest Therapy |
| 3b Medical, INC. | $14.99 | 2024 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.